The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of homologous recombination deficiency in advanced breast cancer treated with trastuzumab deruxtecan.
 
Junghoon Shin
Honoraria - Amgen; AstraZeneca; Daewoong Pharmaceutical; Eisai; Lilly
Consulting or Advisory Role - Lilly
Speakers' Bureau - Amgen; AstraZeneca; Daewoong Pharmaceutical; Eisai; Lilly
 
Ryul Kim
No Relationships to Disclose
 
Ji-Yeon Kim
No Relationships to Disclose
 
Hee Kyung Ahn
No Relationships to Disclose
 
Jin-Seok Ahn
No Relationships to Disclose
 
Young Seok Ju
No Relationships to Disclose
 
Yeon Hee Park
Honoraria - AstraZeneca; Daiichi-Sankyo; Eisai; Gilead Sciences; Helsinn Healthcare; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boryung; Daiichi-Sankyo; Eisai; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Gencurix (Inst); Inocras (Inst); NGeneBio (Inst); Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - Gilad